Patents
Patents for C07J 69 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom (107)
12/2014
12/10/2014CN102516350B 一种具有抗肿瘤活性的甘草次酸修饰物及其制备方法 Glycyrrhetinic acid modifications and preparation method with anti-tumor activity
11/2014
11/25/2014US8895576 Methods of use of cyclopamine analogs
07/2014
07/22/2014US8785635 Cyclopamine analogs
04/2014
04/17/2014WO2014059314A1 Treating brain cancer using agelastatin a (aa) and analogues thereof
01/2014
01/22/2014CN103524594A Method for separating cyclopamine analogs from Veratrum plants by high-speed counter-current chromatography
07/2013
07/16/2013US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling
03/2013
03/13/2013CN101565446B Veratramine degradation product veratrum fluorene aldehyde and the derivatives thereof, as well as the preparation and application thereof
02/2013
02/05/2013CA2727986C Methods for obtaining cyclopamine
01/2013
01/22/2013US8357368 Methods of treating pancreatic or liver cancer using hedgehog antagonists
06/2012
06/27/2012CN102516350A Glycyrrhetinic acid modifier with antitumor activity and preparation method thereof
05/2012
05/31/2012US20120135066 Regulators of the hedgehog pathway, compositions and uses related thereto
05/30/2012CN101565445B Method for preparing high-purity veratramine and jervine
04/2012
04/25/2012EP2443926A2 Cyclopamine analogs
04/24/2012US8163719 Regulators of the hedgehog pathway, compositions and uses related thereto
01/2012
01/03/2012CA2452151C Use of cyclopamine, an inducer of the differentiation and apoptosis of the basal cell carcinoma (bcc) cells, in the treatment of bcc's and other tumors that use the hedgehog/smoothened pathway for proliferation of apoptosis
11/2011
11/16/2011CN102241727A Cyclopamine analogues and methods of use thereof
10/2011
10/27/2011US20110263519 Regulators of the hedgehog pathway, compositions and uses related thereto
09/2011
09/28/2011EP2368551A2 Methods of use for cyclopamine analogs
09/06/2011CA2502293C Ship 1 modulators
08/2011
08/16/2011US7998946 Regulators of the hedgehog pathway, compositions and uses related thereto
03/2011
03/31/2011US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
01/2011
01/13/2011US20110008333 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
11/2010
11/09/2010CA2326654C Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
09/2010
09/08/2010EP2224807A1 Methods for stereoselective reduction
08/2010
08/11/2010EP2216022A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
06/2010
06/16/2010CN101735302A Preparation methods of 12 beta-hydroxyl veratroylzygadenine, veratrosine and veratramine, and applications to treating mental diseases
06/16/2010CN101157716B Dicarbon drop freedelane triterpenoid and preparation method and uses thereof
05/2010
05/05/2010CN1525859B Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
05/04/2010US7708998 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
02/2010
02/02/2010US7655653 Tetrahydrobenzfluorene derivatives
01/2010
01/26/2010CA2505575C 17alpha-hydroxy-14beta-steroids with hormonal effect
01/07/2010WO2010000070A1 Methods for obtaining cyclopamine
01/07/2010CA2727986A1 Methods for obtaining cyclopamine
01/04/2010CA2636807A1 Methods for obtaining cyclopamine
10/2009
10/28/2009CN101565446A Veratramine degradation product veratrum fluorene aldehyde and the derivatives thereof, as well as the preparation and application thereof
10/28/2009CN101565445A Method for preparing high-purity veratramine and jervine
09/2009
09/09/2009EP2096917A2 Cyclopamine analogs
09/02/2009CN100535000C Method of preparing cyclopamine from jervine
08/2009
08/12/2009CN100526329C Production of high-purity peiminine and fritimine
04/2009
04/14/2009CA2386190C Regulators of the hedgehog pathway, compositions and uses related thereto
02/2009
02/11/2009CN101362791A Steroidal alkaloid veratramine, preparation method thereof and antihypertensive application
01/2009
01/13/2009US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors
10/2008
10/16/2008US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto
07/2008
07/29/2008US7405207 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
04/2008
04/09/2008CN101157716A Dicarbon drop freedelane triterpenoid and preparation method and uses thereof
03/2008
03/06/2008US20080058361 Tetrahydrobenzfluorene derivatives
01/2008
01/02/2008EP1458743B1 Tetrahydrobenzfluorene derivatives
12/2007
12/04/2007US7304155 Nonsteroid; enantiomers are selective antagonists of the estrogen beta receptor relative to the alpha receptor; tissue selectivity; fewer estrogen-related side effects; menopause, osteoporosis, hormone replacent therapy, contraceptive, endometriosis; 10-aminoalkyloxyphenyl benzo[b]fluorene 2,8-diols
08/2007
08/15/2007CN101016329A Method of preparing cyclopamine from jervine
07/2007
07/04/2007CN1993343A Tetracyclic compounds as estrogen ligands
06/2007
06/20/2007CN1982328A Production of high-purity peiminine and fritimine
03/2007
03/14/2007EP1761513A1 Tetracyclic compounds as estrogen ligands
12/2006
12/06/2006EP1728797A2 Regulators of the hedgehog pathway, compositions and uses related thereto
06/2006
06/15/2006US20060128639 Regulators of the hedgehog pathway, compositions and uses related thereto
05/2006
05/31/2006EP1235851B1 Regulators of the hedgehog pathway, compositions and uses related thereto
01/2006
01/26/2006US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto
01/19/2006CA2570518A1 Tetracyclic compounds as estrogen ligands
12/2005
12/07/2005CN1230169C Use of cyclopamine in the treatment of psoriasis
09/2005
09/28/2005EP1401438B1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
08/2005
08/10/2005EP1561464A2 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
06/2005
06/02/2005US20050119264 Tetrahydrobenzfluorene derivatives
09/2004
09/22/2004EP1458743A1 Tetrahydrobenzfluorene derivatives
09/01/2004CN1525859A Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
08/2004
08/18/2004CN1522146A Use of cyclopamine in the treatment of psoriasis
07/2004
07/01/2004US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell
06/2004
06/10/2004US20040110663 Hedgehog antagonists, methods and uses related thereto
04/2004
04/01/2004US20040060568 Hedgehog antagonists, methods and uses related thereto
03/2004
03/31/2004EP1401438A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
03/25/2004WO2003040163B1 Immunomodulating saponins, a method for their preparation and their use for vaccines
02/2004
02/11/2004EP1387674A2 Hedgehog antagonists, methods and uses related thereto
02/03/2004US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto
12/2003
12/04/2003WO2002030462A3 Hedgehog antagonists, methods and uses related thereto
11/2003
11/27/2003WO2003040163A3 Immunomodulating saponins, a method for their preparation and their use for vaccines
07/2003
07/03/2003WO2003053994A1 Tetrahydrobenzfluorene derivatives
06/2003
06/12/2003WO2002078703A8 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
05/2003
05/15/2003WO2003040163A2 Immunomodulating saponins, a method for their preparation and their use for vaccines
05/15/2003WO2002030462A9 Hedgehog antagonists, methods and uses related thereto
11/2002
11/07/2002US20020165221 Cellular antigrowth agents
10/2002
10/10/2002WO2002078704A1 Use of cyclopamine in the treatment of psoriasis
10/10/2002WO2002078703A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
09/2002
09/04/2002EP1235851A2 Regulators of the hedgehog pathway, compositions and uses related thereto
08/2002
08/15/2002WO2001027135A9 Regulators of the hedgehog pathway, compositions and uses related thereto
05/2002
05/10/2002WO2001027135A3 Regulators of the hedgehog pathway, compositions and uses related thereto
04/2002
04/18/2002WO2002030462A2 Hedgehog antagonists, methods and uses related thereto
04/18/2002CA2425356A1 Hedgehog antagonists, methods and uses related thereto
12/2001
12/05/2001CN1075802C Asiatic acid derivatives having modified A-ring
10/2001
10/25/2001US20010034337 Antiproliferative agents
10/17/2001EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto
09/2001
09/18/2001US6291516 Contacting the cell with a composition including at least one cyclic amp agonist.
06/2001
06/13/2001EP0944571B1 Asiatic acid derivatives having modified a-ring
04/2001
04/19/2001WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto
01/2001
01/17/2001EP1067939A1 Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
09/2000
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/2000
07/20/2000WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto
06/2000
06/06/2000US6071898 Asiatic acid derivatives having modified A-ring
12/1999
12/15/1999CN1238755A Asiatic acid derivatives having modified A-ring
10/1999
10/21/1999WO1999052534A1 Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
09/1999
09/29/1999EP0944571A1 Asiatic acid derivatives having modified a-ring
10/1998
10/13/1998US5821253 Tetrahydrobenzo a!fluorene compounds and methods of use
1 2